Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANSWER: Ivermectin + Doxycycline in Severe Rosacea
NCT03075891Phase 4Completed
- Sponsor
- Galderma
- Start
- Jul 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial in rosacea comparing Ivermectin + Doxycycline with Ivermectin + Placebo (2 arms). Primary endpoint: Percent Change From Baseline in Inflammatory Lesion Count at 12 weeks. Started Jul 2017; status: completed.
02
Drugs
doxycycline
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03075891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03075891.